Platinum-based combination chemotherapy for the treatment of advanced-stage squamous cell carcinoma of the vulva

Obstet Gynecol. 2012 Aug;120(2 Pt 2):458-460. doi: 10.1097/AOG.0b013e318254fe64.

Abstract

Background: Chemoradiation is an alternative to radical vulvectomy with en bloc node dissection for advanced vulvar cancer. We report a case of complete clinical and pathologic response with chemotherapy alone in a patient with advanced vulvar cancer.

Case: A middle-aged woman known to have had human immunodeficiency virus (HIV) for 10 years was newly diagnosed with advanced-stage squamous carcinoma of the vulva. She was treated with a total of nine cycles of platinum-based combination chemotherapy, with complete clinical and pathologic response. She remains in complete clinical remission without evidence of recurrent disease by noninvasive testing in the absence of any further therapy 24 months after her last chemotherapy treatment.

Conclusion: Platinum-based combination chemotherapy may be used successfully for patients with advanced-stage squamous carcinoma of the vulva.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biopsy
  • Carboplatin / administration & dosage
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Cisplatin / administration & dosage
  • Docetaxel
  • Female
  • HIV Infections / complications
  • HIV*
  • Humans
  • Middle Aged
  • Paclitaxel / administration & dosage
  • Remission Induction
  • Taxoids / administration & dosage
  • Vulvar Neoplasms / drug therapy*
  • Vulvar Neoplasms / pathology

Substances

  • Taxoids
  • Docetaxel
  • Carboplatin
  • Paclitaxel
  • Cisplatin